|
Market Closed -
NYSE
16:04:13 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 263.29 USD | -1.12% |
|
-0.45% | +15.23% |
| 09-29 | Valkai Partners with Abbvie to Apply Advanced Ai Across Targeted Areas of Clinical Development | CI |
| 09-29 | AbbVie Shows Pipeline-Driven Upside Beyond Core Immunology Franchise, BofA Says | MT |
| Market Cap | 471B 415B 392B 356B 668B 45,158B 674B 4,693B 1,810B 23,055B 1,767B 1,728B 74,005B | P/E 2026 * |
33.7x | P/E 2027 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 532B 469B 444B 402B 755B 51,070B 762B 5,308B 2,047B 26,073B 1,998B 1,954B 83,692B | EV / Sales 2026 * |
7.87x | EV / Sales 2027 * | 7.12x |
| Free-Float |
95.71% | Yield 2026 * |
2.6% | Yield 2027 * | 2.71% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
London S.E.
| 0QCV | Delayed | |
|
Xetra
| 4AB | Delayed | |
|
Tradegate
| 4AB | Real-time | |
|
Boerse Muenchen
| 4AB | Real-time | |
|
CBOE
| 0QCV | Real-time | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| 4AB | Delayed | |
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed |
Last Transcript: AbbVie Inc.
| 1 day | -1.12% | ||
| 1 week | -0.45% | ||
| Current month | +2.68% | ||
| 1 month | +3.06% | ||
| 3 months | +3.92% | ||
| 6 months | +25.74% | ||
| Current year | +15.23% |
| 1 week | 261.52 |  | 269.39 |
| 1 month | 246.77 | | 269.39 |
| Current year | 190.75 | | 269.39 |
| 1 year | 190.75 | | 269.39 |
| 3 years | 135.85 | | 269.39 |
| 5 years | 106.86 | | 269.39 |
| 10 years | 55.06 | | 269.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Ed Rapp
BRD | Director/Board Member | 69 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% | ||
| 6/30/26 | Free | Director | 62 | 0.0000% | ||
| 6/30/26 | Free | Director | 134 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | -0.45% | +19.35% | +72.93% | 471B | |
| -0.01% | +1.69% | +63.50% | +117.58% | 1,056B | |
| -1.61% | -0.71% | +48.89% | +70.56% | 655B | |
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | |
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +7.75% | +55.19% | +56.43% | 226B | |
| -0.61% | +0.48% | +34.95% | +100.58% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| 0.00% | +3.53% | +20.88% | -10.50% | 164B | |
| Average | -0.49% | +0.66% | +28.86% | +42.81% | 380.66B | |
| Weighted average by Cap. | -0.60% | +0.81% | +39.04% | +65.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.6B 59.62B 56.38B 51.1B 95.92B 6,488B 96.79B 674B 260B 3,312B 254B 248B 10,632B | 73.5B 64.82B 61.3B 55.56B 104B 7,053B 105B 733B 283B 3,601B 276B 270B 11,559B |
| Net income | 14.07B 12.41B 11.73B 10.63B 19.96B 1,350B 20.14B 140B 54.12B 689B 52.82B 51.66B 2,212B | 19.05B 16.8B 15.89B 14.4B 27.03B 1,828B 27.27B 190B 73.28B 933B 71.52B 69.95B 2,995B |
| Net Debt | 61.59B 54.32B 51.37B 46.56B 87.4B 5,911B 88.19B 614B 237B 3,018B 231B 226B 9,687B | 53.09B 46.82B 44.28B 40.13B 75.33B 5,095B 76.01B 530B 204B 2,601B 199B 195B 8,350B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$263.29 | -1.12% | 3,878,551 |
| 26-09-28 | US$266.28 | +0.73% | 4,429,512 |
| 26-09-25 | US$264.34 | -0.29% | 2,541,718 |
| 26-09-24 | US$265.12 | +0.02% | 3,458,166 |
| 26-09-23 | US$265.08 | -0.05% | 3,469,242 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
